n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amital, H; Bar-Yehuda, S; Barer, F; Cohn, S; Del Valle, L; Farbstein, M; Fishman, P; Fishman-Furman, S; Langevitz, P; Levi, Y; Mader, R; Madi, L; Molad, Y; Ochaion, A; Perez-Liz, G; Reitblat, A; Reitblat, T; Tishler, M; Zabutti, A | 1 |
| Egnaczyk, G; Haskó, G; Salzman, AL; Scott, GS; Shanley, TP; Szabó, C; Virág, L | 1 |
2 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and Arthritis
| Article | Year |
|---|---|
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Arthritis; Blotting, Western; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Leukocytes, Mononuclear; Methotrexate; Middle Aged; Rats; Rats, Inbred Lew; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2006 |
Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
Topics: Adenosine; Animals; Arthritis; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Collagen; Cytokines; Disease Models, Animal; Gene Expression; Macrophage Activation; Macrophage Inflammatory Proteins; Macrophages; Mice; Mice, Inbred DBA; Purinergic P1 Receptor Agonists; RNA, Messenger | 1998 |